| RS2095878223 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 4, Cardiomyopathy |
| RS2095878299 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2095878612 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, Cardiomyopathy |
| RS2095879053 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, Cardiomyopathy |
| RS2095879167 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2095879641 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS2095879705 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2095879885 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2095879886 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy, Cardiomyopathy |
| RS2095880858 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2095880876 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Left ventricular noncompaction 10, Hypertrophic cardiomyopathy 4 |
| RS2095880923 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, Cardiomyopathy |
| RS2095880935 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2095881691 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2095881732 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Left ventricular noncompaction 10, Hypertrophic cardiomyopathy 4 |
| RS2095883336 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy, Cardiomyopathy |
| RS2095883374 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2095883508 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2095883614 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, Cardiomyopathy |
| RS2095884867 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Hypertrophic cardiomyopathy |
| RS2095884984 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2095885868 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2095885899 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS2095885930 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS2095886347 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2095887873 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2095887900 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2095889088 |
MYBPC3
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hypertrophic cardiomyopathy |
| RS2095889156 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2095889815 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2095889902 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2095889992 |
MYBPC3
|
Health Risk |
Pathogenic |
Cardiomyopathy, Cardiomyopathy |
| RS2095890222 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2095890370 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, Cardiomyopathy |
| RS2095890455 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy 1, Hypertrophic cardiomyopathy 4 |
| RS2095890510 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2095890782 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2095891230 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2095891398 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy 4 |
| RS2095891411 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2095893477 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 4, Hypertrophic cardiomyopathy |
| RS2095894010 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2095894178 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy, Cardiomyopathy |
| RS2095895403 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2095896008 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2095896870 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2095898363 |
MYBPC3
|
Health Risk |
Likely pathogenic |
— |
| RS2095898456 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, Cardiomyopathy |
| RS2095898504 |
MYBPC3
|
Health Risk |
Pathogenic |
Cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2095898532 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2095898569 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2095899755 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2095900581 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2095900669 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiomyopathy, Cardiomyopathy |
| RS2095906404 |
SPI1
|
Health Risk |
Likely pathogenic |
PU.1-mutated agammaglobulinemia, Agammaglobulinemia 10 |
| RS2095906547 |
SPI1
|
Health Risk |
Likely pathogenic |
PU.1-mutated agammaglobulinemia, Agammaglobulinemia 10 |
| RS2095916574 |
SPI1
|
Health Risk |
Pathogenic |
PU.1-mutated agammaglobulinemia, Agammaglobulinemia 10 |
| RS2095919119 |
ANK2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2095976276 |
DST
|
Health Risk |
Pathogenic |
Hereditary sensory and autonomic neuropathy type 6, Epidermolysis bullosa simplex 3 |
| RS2095978390 |
DST
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex 3, localized or generalized intermediate |
| RS2095982231 |
CAMTA1
|
Health Risk |
Pathogenic |
Cerebellar dysfunction with variable cognitive and behavioral abnormalities, Cerebellar dysfunction with variable cognitive and behavioral abnormalities |
| RS2095985353 |
CAMTA1
|
Health Risk |
Pathogenic |
— |
| RS2095989161 |
CAMTA1
|
Health Risk |
Likely pathogenic |
Cerebellar dysfunction with variable cognitive and behavioral abnormalities, Cerebellar dysfunction with variable cognitive and behavioral abnormalities |
| RS2096016231 |
ANK2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2096136332 |
CAMTA1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2096224408 |
AEBP1
|
Health Risk |
Likely pathogenic |
— |
| RS2096226168 |
AEBP1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic-like |
| RS2096229863 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS2096231961 |
AEBP1
|
Health Risk |
Likely pathogenic |
— |
| RS2096232673 |
AEBP1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic-like |
| RS2096234308 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2096270423 |
GCK
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young type 2 |
| RS2096270569 |
GCK
|
Health Risk |
Pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2096270595 |
GCK
|
Health Risk |
Uncertain significance/Uncertain risk allele |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS2096270699 |
GCK
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young type 2 |
| RS2096270755 |
GCK
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Maturity-onset diabetes of the young |
| RS2096271045 |
KCNMA1
|
Health Risk |
Likely pathogenic |
Cerebellar atrophy, developmental delay |
| RS2096271295 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Maturity-onset diabetes of the young |
| RS2096271425 |
GCK
|
Health Risk |
Pathogenic/Likely pathogenic/Likely risk allele |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young |
| RS2096271467 |
GCK
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2096271482 |
GCK
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young, Monogenic diabetes |
| RS2096271511 |
GCK
|
Health Risk |
Pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2096271597 |
GCK
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young |
| RS2096271616 |
GCK
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Maturity-onset diabetes of the young type 2 |
| RS2096271812 |
GCK
|
Health Risk |
Uncertain significance/Uncertain risk allele |
Permanent neonatal diabetes mellitus, Type 2 diabetes mellitus |
| RS2096271919 |
GCK
|
Health Risk |
Uncertain significance/Uncertain risk allele |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS2096273846 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS2096273902 |
GCK
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young, Monogenic diabetes |
| RS2096275721 |
GCK
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young, Monogenic diabetes |
| RS2096278285 |
GCK
|
Health Risk |
Pathogenic/Likely pathogenic |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS2096278772 |
GCK
|
Health Risk |
Uncertain significance/Uncertain risk allele |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young |
| RS2096278825 |
GCK
|
Health Risk |
Pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2096278847 |
GCK
|
Health Risk |
Pathogenic/Likely pathogenic |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young |
| RS2096280050 |
GCK
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young, Monogenic diabetes |
| RS2096280084 |
GCK
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS2096280206 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young type 2 |
| RS2096281702 |
GCK
|
Health Risk |
Pathogenic/Likely pathogenic |
Maturity-onset diabetes of the young type 2, Maturity-onset diabetes of the young |
| RS2096281719 |
GCK
|
Health Risk |
Likely pathogenic |
— |
| RS2096281726 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS2096281776 |
GCK
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |